David S. Morris, MD, FACS, presented “Upper Tract Urothelial Cancer: Challenges and Opportunities for Treating the Unmet Medical Need” for the Grand Rounds in Urology audience in December 2019.
How to cite: Morris, David S. “Upper Tract Urothelial Cancer: Challenges and Opportunities for Treating the Unmet Medical Need” December, 2019. Accessed Oct 2026. https://grandroundsinurology.com/upper-tract-urothelial-cancer-challenges-and-opportunities-for-treating-the-unmet-medical-need/
Upper Tract Urothelial Cancer: Challenges and Opportunities for Treating the Unmet Medical Need – Summary:
David S. Morris, MD, FACS, discusses current methods of diagnosing and risk-stratifying upper tract urothelial cancer (UTUC), as well as the implications of disease risk on treatment decisions. He notes the unmet need for an effective kidney-sparing option for low-risk patients, and the potential for chemoablation with UGN-101 to address this need based on findings from the OLYMPUS trial.
ABOUT THE AUTHOR
David S. Morris, MD, FACS, is President of Urology Associates, P.C., in Nashville, Tennessee, where he also serves as Co-Director of the Advanced Therapeutics Center and Clinical Research Department. His clinical interests include urologic oncology, with a particular focus on advanced prostate cancer, as well as robotic and laparoscopic surgery, endourology, stone disease, and reconstructive urology.
